Basic Information
| LncRNA/CircRNA Name | XLOC_013014 |
| Synonyms | LINC01233, XLOC_013014 |
| Region | GRCh38_19:22532626-22533494 |
| Ensemble | ENSG00000269364 |
| Refseq | NR_110663 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | esophageal squamous cell carcinoma |
| ICD-0-3 | NA |
| Methods | Microarray, qPCR etc. |
| Sample | OSCC tissues |
| Expression Pattern | differential expression |
| Function Description | we identified a three-lncRNA signature (including the lncRNAs ENST00000435885.1, XLOC_013014 and ENST00000547963.1) which classified the patients into two groups with significantly different overall survival . The signature was applied to the test group and independent cohort and showed similar prognostic values in both. |
| Pubmed ID | 24522499 |
| Year | 2014 |
| Title | LncRNA profile study reveals a three-lncRNA signature associated with the survival of patients with oesophageal squamous cell carcinoma. |
External Links
| Links for XLOC_013014 | GenBank HGNC NONCODE |
| Links for esophageal squamous cell carcinoma | OMIM COSMIC |